Insights On Drug Development

  1. The World Outside Influencing Your Outsourcing Internals 6/26/2025

    Tariffs, geopolitical gyrations, (pending) laws such as the BIOSECURE Act; all affect your outsourcing optionality and decision-making. Our panel of internationally savvy biopharma executives provide some guiding insights.

  2. Outsourcing Biologics Comes With "Demands" 6/26/2025

    Chief Editor Louis Garguilo opens the discussion with our panelists on the state of biologics outsourcing, and the "must haves" for sponsors of their CDMOs.

  3. Negotiating With Your CDMOs 6/26/2025

    Reza Oliyai, President and CEO, Oliyai Consulting Corporation, informs our Outsourced Pharma Live attendees of his thoughts on negotiating to get the outsourcing relationship and scope of work you need at your CDMO.

  4. Where CDMOs Can Improve For CGT Customers? 6/26/2025

    Donna Rill, Chief Technology Officer, Triumvira Immunologics, has advice for CDMOs to improve their service to CGT customers, and conversely, where drug developers can improve as well.

  5. Are You Asking For Unrealistic Flexibility At Your CDMO? 6/26/2025

    Our experienced Outsourced Pharma Live panel considers what is doable, and what is not, when it comes to the demands some sponsors put on CDMOs.

  6. Budgeting Key Component In Biologics Flexibility At CDMOs 6/26/2025

    You want flexibility in scheduling, contracts, and the entire CDMO relationship. While money can't buy you love, it can go a long way in getting that more flexible partnership.

  7. An Intro To CDMO Flexibility 6/26/2025

    Seshu Tummala, Executive Director at Uniquity Bio discusses some of the components of "CDMO flexibility" when it comes to biologics outsourcing relationships.

  8. Developing Amorphous Solid Dispersions For Poorly Soluble Drugs 6/20/2025

    Discover how a strategic amorphous solid dispersion approach improved bioavailability and advanced a low-solubility compound toward clinical readiness in just four weeks.

  9. Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development 6/19/2025

    Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

  10. Formulation Development 101: What Is It And Why Does It Matter? 6/16/2025

    Discover why formulation development is a critical, high-stakes process that transforms scientific innovation into safe, effective therapies for patients.